PSA test for men could get a second life for breast cancer in women

Jul 13, 2011

The widely known PSA blood test for prostate cancer in men may get a second life as a much-needed new test for breast cancer, the most common form of cancer in women worldwide, scientists are reporting in a new study in the ACS journal Analytical Chemistry.

Chien Chou and colleagues say that the prostate-specific antigen (PSA) measured in the test also is a potential biomarker of breast cancer in women. However, levels of PSA in healthy women are usually so small that only ultrasensitive tests can measure them.

To improve PSA detection in women, the researchers built a tiny fiber-optic biosensor using and PSA antibodies to detect and report PSA levels via a fluorescent signal. The biosensor's sensitivity (its ability to detect elevated PSA levels in cases of breast cancer) and its specificity (how well it avoids false predictions of breast cancer) are comparable to those found in using PSA as a biomarker for prostate cancer. "Furthermore, these values may compare favorably with the sensitivity and specificity of the current screening methods for breast cancer such as clinical examination… and mammogram," the scientists report.

Explore further: Devices designed to identify pathogens in food

More information: “Discrimination of breast cancer by measuring prostate-specific antigen levels in women serum” Anal. Chem., 2011, 83 (13), pp 5324–5328. DOI: 10.1021/ac200754x

Abstract
Prostate-specific antigen (PSA) has been reported to be a potential biomarker of breast cancer. Serum PSA of normal women is around 1 pg/mL, which is usually undetectable by current assay methods; thus an ultrasensitive measurement of PSA expression in women's serum is necessary to distinguish normal from malignant breast diseases. To enhance the sensitivity of conventional immunoassay technology for the detection of PSA in sera, we adopted a localized surface plasmon coupled fluorescence fiber-optic biosensor, which combines a sandwich immunoassay with the localized surface plasmon technique. The concentration of total PSA (t-PSA) (from 0.1 to 1000 pg/mL) in phosphate-buffered saline solution and the normalized fluorescence signal exhibit a linear relationship where the correlation coefficient is 0.9574. In addition, the concentration of additional t-PSA in 10-fold-diluted healthly women's serum across a similar range was measured. The correlation coefficient for this measurement is 0.9142. In clinical serum samples, moreover, the experimental results of t-PSA detection show that both the mean value and median of normalized fluorescence signals in the breast cancer group (155.2 and 145.7, respectively) are higher than those in the noncancer group (46.6 and 37.1, respectively). We also examined the receiver operating characteristic curve for t-PSA, and the area under the curve (AUC) is estimated to be 0.9063, the AUC being used to measure the performance of a test to correctly identify diseased and nondiseased subjects.

Related Stories

New prostate cancer test gives more accurate diagnosis

Apr 06, 2011

In a large multi-center clinical trial, a new PSA test to screen for prostate cancer more accurately identified men with prostate cancer -- particularly the aggressive form of the disease -- and substantially reduced false ...

Recommended for you

Devices designed to identify pathogens in food

5 hours ago

Researchers at the National Polytechnic Institute (IPN) in Mexico have developed a technology capable of identifying pathogens in food and beverages. This technique could work in the restaurant industry as ...

Biosensor may improve clinical diagnosis of influenza A

6 hours ago

Sensors based on special sound waves known as surface acoustic waves (SAWs) are capable of detecting tiny amounts of antigens of Influenza A viruses. Developed by A*STAR researchers, the biosensors have the ...

New chip makes testing for antibiotic-resistant bacteria faster, easier

23 hours ago

We live in fear of 'superbugs': infectious bacteria that don't respond to treatment by antibiotics, and can turn a routine hospital stay into a nightmare. A 2015 Health Canada report estimates that superbugs have already cost Canadians $1 billion, and are a "serious and growing issue." Each year two million people in the U.S. contract antibiotic-re ...

Use your smartphone for biosensing

May 26, 2015

An Australian research team has shown that smartphones can be reconfigured as cost-effective, portable bioanalytical devices, with details reported in the latest edition of the Open Access Journal 'Sensors'.

Faster, portable microbial analysis in the field

May 25, 2015

Until recently, it took hours – sometimes days – to analyze biological samples after they were frozen in the field and brought back to the laboratory. But now there is a faster, cheaper and smaller way ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.